Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-Small-Cell Lung (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00480831
What this trial is testing

PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g)

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc. 128
Testing effectiveness (Phase 2)Looking for participantsNCT07079475
What this trial is testing

Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)

Who this might be right for
Non-Small Cell Lung Cancer
Dizal Pharmaceuticals 220
Not applicableStudy completedNCT00019201
What this trial is testing

Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
National Cancer Institute (NCI)
Not applicableUnknownNCT04708639
What this trial is testing

Monitoring Alectinib Treatment by Detection of ALK Translocations in Serial Blood Samples From Non-Small Cell Lung Cancer Patients

Who this might be right for
Lung CancerALK Gene MutationResistance, Disease+1 more
Aarhus University Hospital 40
Not applicableStudy completedNCT01074177
What this trial is testing

Understanding Mechanisms of Acquired Resistance to BIBW2992

Who this might be right for
Non-small Cell Lung CancerEGFR Mutations
Massachusetts General Hospital 24
Testing effectiveness (Phase 2)Ended earlyNCT03237377
What this trial is testing

Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Not applicableEnded earlyNCT04106167
What this trial is testing

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Who this might be right for
Advanced Solid TumorLymphomaGastric Cancer+15 more
Fate Therapeutics 20
Large-scale testing (Phase 3)Study completedNCT03150875
What this trial is testing

A Study Comparing the Efficacy and Safety Between IBI308 and Docetaxel in Patients With Advanced or Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 290
Testing effectiveness (Phase 2)Looking for participantsNCT06754930
What this trial is testing

SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 400
Testing effectiveness (Phase 2)Looking for participantsNCT06378892
What this trial is testing

Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on Lorlatinib

Who this might be right for
Non Small Cell Lung Cancer MetastaticALK Gene Mutation
Centro di Riferimento Oncologico - Aviano 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06297811
What this trial is testing

Myeloprotection With Trilaciclib in Pan-cancer Population

Who this might be right for
Non-Small Cell Lung CancerBreast CancerEndometrial Cancer+2 more
Sun Yat-sen University 132
Not applicableStudy completedNCT00875901
What this trial is testing

Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)

Who this might be right for
Non-Small Cell Lung Cancer
University of Florida 23
Testing effectiveness (Phase 2)Study completedNCT03450330
What this trial is testing

Assessing an Oral Janus Kinase Inhibitor, AZD4205, in Combination With Osimertinib in Patients Who Have Advanced Non-small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Dizal Pharmaceuticals 10
Post-approval studies (Phase 4)Study completedNCT01402089
What this trial is testing

Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients

Who this might be right for
Non Small-cell Lung CancerRenal-cell CancerGastrointestinal Stroma Tumor
Markus Joerger 54
Not applicableNot Yet RecruitingNCT07198620
What this trial is testing

A Real-World Study of IBI351 for KRAS G12C+ NSCLC in China

Who this might be right for
Lung Cancer (NSCLC)
Guangdong Association of Clinical Trials 600
Not applicableLooking for participantsNCT04790682
What this trial is testing

LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG

Who this might be right for
Metastatic Lung Cancer
Institut Curie 300
Testing effectiveness (Phase 2)Study completedNCT01296113
What this trial is testing

Chemotherapy for Lung Cancer in HIV-positive Patients

Who this might be right for
Non-small Cell Lung CancerHiv-positive
Intergroupe Francophone de Cancerologie Thoracique 61
Testing effectiveness (Phase 2)UnknownNCT03904823
What this trial is testing

Famitinib in Combination With HS-10296 in Patients With EGFR-mutant NSCLC

Who this might be right for
EGFR-mutant Non-Small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 58
Testing effectiveness (Phase 2)Study completedNCT00923312
What this trial is testing

Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
CureVac 46
Testing effectiveness (Phase 2)WithdrawnNCT04987281
What this trial is testing

Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study

Who this might be right for
Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the LungStage I Lung Cancer AJCC v8
M.D. Anderson Cancer Center
Next Page